Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sharon Evertson

Psychiatry Fort Lauderdale, FL Medical Doctor

NPI 1306972575 CMS profile 285713

2900 W Prospect Rd, Fort Lauderdale, FL 33309

Open in the dashboard

General payments

$3,840

180 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$119,270 paid to institutions, not to them · program years 2020–2025

Through program year 2025, Sharon Evertson of Fort Lauderdale, FL is reported in the CMS Open Payments database as having received $3,840 across 180 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $119,270 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 86th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $306 12
2024 General $735 37
2023 General $710 32
2022 General $551 24
2021 General $515 20
2020 General $291 17
2019 General $732 38

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sharon Evertson
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Sharon Evertson were reported at $306. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Sharon Evertson Psychiatry median Middle half National median
2019 $732 $184 $59–$605 $163
2020 $291 $119 $36–$372 $114
2021 $515 $143 $43–$576 $132
2022 $551 $153 $50–$590 $149
2023 $710 $170 $56–$651 $160
2024 $735 $179 $57–$673 $164
2025 $306 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Otsuka America Pharmaceutical, Inc. $1,046 46 payments
  2. Janssen Pharmaceuticals, Inc $1,002 39 payments
  3. Alkermes, Inc. $549 28 payments
  4. Teva Pharmaceuticals USA, Inc. $422 25 payments
  5. Allergan Inc. $216 13 payments
  6. Sunovion Pharmaceuticals Inc. $186 10 payments
  7. E.R. Squibb & Sons, L.L.C. $108 5 payments
  8. Indivior Inc. $105 5 payments
  9. ITI, Inc. $71 2 payments
  10. Neurocrine Biosciences, Inc. $48 3 payments
  11. Other $87 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,546 173 payments
  2. Education $294 7 payments
Products named General payments · program years 2019–2025
  1. INVEGA SUSTENNA $1,002 39 payments
  2. ABILIFY MAINTENA $886 38 payments
  3. ARISTADA Cns $529 27 payments
  4. ARISTADA Cns $529 27 payments
  5. ARISTADA Cns $436 22 payments
  6. ARISTADA Cns $436 22 payments
  7. ARISTADA INITIO $372 19 payments
  8. ABILIFY ASIMTUFII $364 15 payments
  9. LYBALVI $271 14 payments
  10. INVEGA TRINZA $219 13 payments
  11. Other $1,687 99 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

180 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record